->

I-Tag: I-Juno Therapeutics

Ikhaya / Unyaka Omisiwe

, , , ,

I-Lisocabtagene maraleucel igunyazwe yi-FDA yokwelashwa komugqa wesibili we-B-cell lymphoma enkulu

Julayi 2022: I-Lisocabtagene maraleucel (i-Breyanzi, i-Juno Therapeutics, Inc.) igunyazwe yi-Food and Drug Administration ezigulini ezikhulile ezine-B-cell lymphoma (LBCL) ezinesifo esingavumelani ne-chemoi yomugqa wokuqala.

Qala ingxoxo
Siku-inthanethi! Xoxa Nathi!
Skena ikhodi
Sawubona,

Siyakwamukela kuCancerFax!

ICancerFax iyinkundla yokuphayona ezinikele ekuxhumaniseni abantu ababhekene nomdlavuza oseqophelweni eliphezulu ngemithi yokwelapha yamangqamuzana efana ne-CAR T-Cell therapy, ukwelashwa kwe-TIL, nezivivinyo zomtholampilo emhlabeni wonke.

Sazise ukuthi yini esingakwenzela yona.

1) Ukwelashwa komdlavuza phesheya?
2) Ukwelashwa kwe-CAR T-Cell
3) Umuthi wokugomela umdlavuza
4) Ukubonisana ngevidiyo eku-inthanethi
5) Ukwelashwa kweProton